ADRES Int'l Biotech Consultation & Execution Revenue

Biotechnology Research • Rehovot, Center District, Israel • 21-50 Employees

ADRES Int'l Biotech Consultation & Execution revenue & valuation

Annual revenue	$1,967,765
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$6,300,000
Total funding	No funding

Key Contacts at ADRES Int'l Biotech Consultation & Execution

Roy Zaibel

Chief Executive Officer

Inbal Hacmon

Chief Executive Officer

Tamar Oved

Qa & Cmc Director And Consultant At Adres

Lital Israeli Yagev

Scientific & Regulatory Affairs Director

Company overview

Headquarters	2 Yitzhak Modai St., Rehovot, 7608804, IL
Phone number	+97289319585
Website	adres.co.il
NAICS	541714
Keywords	Gene Therapy, Biopharma, Consulting, Quality Assurance, Medical Device, Regulatory Affairs, FDA, Clinical Studies, Combination Products, Biomedicine, Orphan Drugs, EMA, Novel Drugs, MOH, Cmc/Engineering, Ind/Impd/Nda/Bla, Pre-Clinical Studies
Founded	2009
Employees	21-50
Socials

ADRES Int'l Biotech Consultation & Execution Email Formats

ADRES Int'l Biotech Consultation & Execution uses 4 email formats. The most common is {first initial} (e.g., j@adres.bio), used 46.7% of the time.

Format	Example	Percentage
{first initial}	j@adres.bio	60%
{first name}	john@adres.co.il	26.7%
{first initial}{last name}	jdoe@adres.co.il	13.3%

Employees by Management Level

Total employees: 21-50

Seniority

Employees

C-Suite

Director

Manager

Employees by Department

ADRES Int'l Biotech Consultation & Execution has 7 employees across 4 departments.

Departments

Number of employees

Funding Data

ADRES Int'l Biotech Consultation & Execution has never raised funding before.

Frequently asked questions

ADRES Int'l Biotech Consultation & Execution is located in Rehovot, Center District, IL.

You can reach ADRES Int'l Biotech Consultation & Execution at +97289319585.

ADRES Int'l Biotech Consultation & Execution generates an estimated annual revenue of $1,967,765. This revenue figure reflects the company's market position and business performance in its industry.

ADRES Int'l Biotech Consultation & Execution has an estimated valuation of $6,300,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

ADRES Int'l Biotech Consultation & Execution was founded in 2009, making it 17 years old. The company has established itself as a significant player in its industry over this time.

ADRES Int'l Biotech Consultation & Execution has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contacts at ADRES Int'l Biotech Consultation & Execution

Roy Zaibel

Chief Executive Officer

Inbal Hacmon

Chief Executive Officer

Tamar Oved

Qa & Cmc Director And Consultant At Adres

Lital Israeli Yagev

Scientific & Regulatory Affairs Director

4.8

40,000 users